Societal CDMO, Inc.
Healthcare · Pharmaceutical Preparations · PA · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | |
|---|---|---|---|---|---|---|
| Revenue | $94.6M | $90.2M | $75.4M | $66.5M | $99.2M | $77.3M |
| Operating income | −$3.6M | $279,000 | $412,000 | −$8.3M | $23.6M | $12.5M |
| Net income | −$13.3M | −$19.9M | −$11.4M | −$27.5M | −$18.6M | −$79.7M |
| Total assets | $153.5M | $157.4M | $160.3M | $103.4M | $110.5M | $155.5M |
| Total liabilities | $94.8M | $97.6M | $118.3M | $117.5M | $117.2M | $175.0M |
| Equity | $58.7M | $59.9M | $42.1M | −$14.1M | −$6.7M | −$19.5M |
| EPS (diluted) | $-0.14 | $-0.34 | $-0.26 | $-1.16 | $-0.79 | $-3.90 |
| Shares out. | 84.9M | 56.4M | 31.0M | 23.4M | 21.9M | 19.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- −3.8%
- Net margin
- −14.0%
- Return on equity
- −22.6%
- Return on assets
- −8.6%
- Return on capital (ROCE)
- −3.5%
- Liabilities / assets
- 61.8%
- Debt / equity
- 1.62×
- Book value / share
- $0.69
- Revenue growth (YoY)
- 4.9%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Altman Z″ (distress)
- -5.28distress
- Accruals / assets
- −8.0%clean
- Beneish M-Score
- -2.63normal
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 3 warning● 2 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsApr 8, 2024
- Other material eventMar 15, 2024
- Entered a material agreement · Regulation FD disclosureFeb 28, 2024
- Entered a material agreement · Delisting / listing-standard noticeNov 28, 2023
- Results of operations · Regulation FD disclosureNov 8, 2023
- Costs from exit or disposal · Regulation FD disclosureSep 20, 2023
- Entered a material agreementAug 28, 2023
- Director / officer changeAug 23, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12GApr 18, 2024
- EFFECTApr 11, 2024
- EFFECTApr 11, 2024
- EFFECTApr 11, 2024
- SC 13D/AApr 9, 2024
- 4OWNERSHIP DOCUMENTApr 8, 2024
- 4OWNERSHIP DOCUMENTApr 8, 2024
- 4OWNERSHIP DOCUMENTApr 8, 2024
- 4OWNERSHIP DOCUMENTApr 8, 2024
- 4OWNERSHIP DOCUMENTApr 8, 2024
- 4OWNERSHIP DOCUMENTApr 8, 2024
- 4OWNERSHIP DOCUMENTApr 8, 2024
- 4OWNERSHIP DOCUMENTApr 8, 2024
- 4OWNERSHIP DOCUMENTApr 8, 2024
- 4OWNERSHIP DOCUMENTApr 8, 2024